ExpreS2ion Biotech EBITDA vs. Cash And Equivalents

EXPRS2 Stock  SEK 19.24  0.66  3.32%   
Considering the key profitability indicators obtained from ExpreS2ion Biotech's historical financial statements, ExpreS2ion Biotech Holding may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess ExpreS2ion Biotech's ability to earn profits and add value for shareholders.
For ExpreS2ion Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ExpreS2ion Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ExpreS2ion Biotech Holding utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ExpreS2ion Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ExpreS2ion Biotech Holding over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between ExpreS2ion Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if ExpreS2ion Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ExpreS2ion Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ExpreS2ion Biotech Cash And Equivalents vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ExpreS2ion Biotech's current stock value. Our valuation model uses many indicators to compare ExpreS2ion Biotech value to that of its competitors to determine the firm's financial worth.
ExpreS2ion Biotech Holding is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in cash and equivalents category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ExpreS2ion Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ExpreS2ion Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

ExpreS2ion Cash And Equivalents vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

ExpreS2ion Biotech

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(45.5 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

ExpreS2ion Biotech

Cash

 = 

Bank Deposits

+

Liquidities

 = 
10.14 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

ExpreS2ion Cash And Equivalents Comparison

ExpreS2ion Biotech is currently under evaluation in cash and equivalents category among its peers.

ExpreS2ion Biotech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ExpreS2ion Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ExpreS2ion Biotech will eventually generate negative long term returns. The profitability progress is the general direction of ExpreS2ion Biotech's change in net profit over the period of time. It can combine multiple indicators of ExpreS2ion Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people.

ExpreS2ion Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ExpreS2ion Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ExpreS2ion Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ExpreS2ion Biotech's important profitability drivers and their relationship over time.

Use ExpreS2ion Biotech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ExpreS2ion Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will appreciate offsetting losses from the drop in the long position's value.

ExpreS2ion Biotech Pair Trading

ExpreS2ion Biotech Holding Pair Trading Analysis

The ability to find closely correlated positions to ExpreS2ion Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ExpreS2ion Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ExpreS2ion Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ExpreS2ion Biotech Holding to buy it.
The correlation of ExpreS2ion Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ExpreS2ion Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ExpreS2ion Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ExpreS2ion Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your ExpreS2ion Biotech position

In addition to having ExpreS2ion Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Stores Thematic Idea Now

Stores
Stores Theme
Companies providing different types of retail and wholesale services. The Stores theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Stores Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in ExpreS2ion Stock

To fully project ExpreS2ion Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ExpreS2ion Biotech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ExpreS2ion Biotech's income statement, its balance sheet, and the statement of cash flows.
Potential ExpreS2ion Biotech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ExpreS2ion Biotech investors may work on each financial statement separately, they are all related. The changes in ExpreS2ion Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ExpreS2ion Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.